1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Anup Kasi: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab CEND-1, Panitumumab, Folfirinox - Colon Cancer, Pancreas Cancer | Phase 1 / Phase 2 | Unknown | Anup Kasi | 50 | 2021-10-20 | 2024-12-17 |
Colonic Neoplasms (1) · Gastrointestinal Neoplasms (1) · Pancreatic Neoplasms (1)
Oxaliplatin (1) · Panitumumab (1) · folfirinox (1)
United States (1)